Vaxart, Inc.: Form 10-Q for the period ended Sep 24, 2011
Filed with the SEC on Nov 2, 2011 and accepted by EDGAR at Nov 2, 2011, 17:09 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2011-09-24. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2011-06-26 to 2011-09-24 | $1.1m | us-gaap:Revenues |
| Revenue | 9 months2010-12-26 to 2011-09-24 | $14.0m | us-gaap:Revenues |
| Cost of revenue | 3 months2011-06-26 to 2011-09-24 | $344.0k | us-gaap:CostOfServices |
| Cost of revenue | 9 months2010-12-26 to 2011-09-24 | $1.5m | us-gaap:CostOfServices |
| Research and development | 3 months2011-06-26 to 2011-09-24 | $4.4m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2010-12-26 to 2011-09-24 | $16.2m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2011-06-26 to 2011-09-24 | −$4.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2010-12-26 to 2011-09-24 | −$7.8m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2011-06-26 to 2011-09-24 | −$2.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2010-12-26 to 2011-09-24 | −$2.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2011-06-26 to 2011-09-24 | $78.0k | us-gaap:NetIncomeLoss |
| Net income | 9 months2010-12-26 to 2011-09-24 | −$2.5m | us-gaap:NetIncomeLoss |
| Diluted shares (weighted) | 3 months2011-06-26 to 2011-09-24 | 42,397,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2010-12-26 to 2011-09-24 | 42,269,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2010-12-26 to 2011-09-24 | −$14.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2010-12-26 to 2011-09-24 | $1.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2011-09-24 | $92.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2011-09-24 | $103.8m | us-gaap:AssetsCurrent |
| Total assets | At period end2011-09-24 | $104.1m | us-gaap:Assets |
| Current liabilities | At period end2011-09-24 | $9.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2011-09-24 | $43.4m | us-gaap:Liabilities |
| Shareholders' equity | At period end2011-09-24 | $60.7m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001193125-11-292989. Last ingested by Listed: Nov 5, 2026, 18:48 ET. Listed shows no prices and gives no investment advice.